Evidence map›Paper›PMID 33565190›Full record

ArticleHuman mutation2021

TAOK1 is associated with neurodevelopmental disorder and essential for neuronal maturation and cortical development.

Geeske M van Woerden, Melanie Bos, Charlotte de Konink, Ben Distel, Rossella Avagliano Trezza, Natasha E Shur, Kristin Barañano, Sonal Mahida, Anna Chassevent, Allison Schreiber and 37 more

Open access · bronzeAbstract read
In one paragraph

Article in Human mutation, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
15.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 63 citations in OpenAlex.

  1. International journal of molecular sciences · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Expanding the phenotype and genotype spectrum of TAOK1 neurodevelopmental disorder and delineating TAOK2 neurodevelopmental disorder.Genetics in medicine : official journal of the American College of Medical Genetics · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Inherited and de novo variants extend the etiology ofCold Spring Harbor molecular case studies · 2022
    Article
  19. Article
  20. Paternal De Novo Variant ofFrontiers in genetics · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors at 18 institutions in 5 countries.

Geeske M van WoerdenDepartment of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0003-2492-9239
Melanie BosDepartment of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.ORCID 0000-0003-1833-786X
Charlotte de KoninkDepartment of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
Ben DistelDepartment of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0002-3046-205X
Rossella Avagliano TrezzaDepartment of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0002-1857-5449
Natasha E ShurDivision of Genetics and Metabolism, Rare Disease Institute, Children's National Medical Center, Washington, District of Columbia, USA.
Kristin BarañanoDepartment of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Sonal MahidaDepartment of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Anna ChasseventDepartment of Neurogenetics, Kennedy Krieger Institute, Baltimore, Maryland, USA.
Allison SchreiberGenomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Angelika L ErwinGenomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0002-8791-0554
Karen W GrippDivision of Medical Genetics, Nemours/A.I. duPont Hospital for Children, Wilmington, Delaware, USA.
Fatima RehmanDepartment of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
Saskia BrullemanDepartment of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.
Róisín McCormackDepartment of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0002-8356-9950
Gwynna de GeusDepartment of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0002-2000-3298
Louisa KalsnerDepartments of Neurology and Pediatrics, Connecticut Children's Medical Center and University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Arthur SorlinUMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.ORCID 0000-0001-8008-9145
Ange-Line BruelUMR1231 GAD, Inserm, Université Bourgogne-Franche Comté, Dijon, France.ORCID 0000-0002-0526-465X
David A KoolenDepartment of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
Melissa K GabrielDepartment of Clinical Diagnostics, Ambry Genetics, Aliso Viejo, California, USA.
Mari RossiDepartment of Clinical Diagnostics, Ambry Genetics, Aliso Viejo, California, USA.
David R FitzpatrickMRC Human Genetics Unit, MRC IGMM, University of Edinburgh, Edinburgh, UK.
Andrew O M WilkieClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID 0000-0002-2972-5481
Eduardo CalpenaClinical Genetics Group, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.ORCID 0000-0001-6399-6528
David JohnsonOxford Craniofacial Unit, Oxford University Hospital NHS Foundation Trust, John Radcliffe Hospital, Oxford, UK.
Alice BrooksDepartment of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.
Marjon van SlegtenhorstDepartment of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.
Julie FleischerDepartment of Pediatrics, SIU School of Medicine, Springfield, Illinois, USA.
Daniel GroepperDepartment of Pediatrics, SIU School of Medicine, Springfield, Illinois, USA.
Kristin LindstromDivision of Genetics and Metabolism, Phoenix Children's Hospital, Phoenix, Arizona, USA.
A Micheil InnesDepartment of Medical Genetics and Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.ORCID 0000-0001-9881-5467
Allison GoodwinVCU Medical Center, Clinical Genetics Services, Richmond, Virginia, USA.
Jennifer HumbersonDivision of Pediatric Genetics, Department of Pediatrics, University of Virginia Medical Center, Charlottesville, Virginia, USA.
Amanda NoyesGeneDx, Gaithersburg, Maryland, USA.
Katherine G LangleyGeneDx, Gaithersburg, Maryland, USA.
Aida TelegrafiGeneDx, Gaithersburg, Maryland, USA.
Amy BlevinsGeneDx, Gaithersburg, Maryland, USA.
Jessica HoffmanGeneDx, Gaithersburg, Maryland, USA.
Maria J Guillen SacotoGeneDx, Gaithersburg, Maryland, USA.
Jane JuusolaGeneDx, Gaithersburg, Maryland, USA.
Kristin G MonaghanGeneDx, Gaithersburg, Maryland, USA.
Sumit PunjGeneDx, Gaithersburg, Maryland, USA.
Marleen SimonDepartment of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
Rolph PfundtDepartment of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
Ype ElgersmaDepartment of Neuroscience, Erasmus MC, Rotterdam, The Netherlands.ORCID 0000-0002-3758-1297
Tjitske KleefstraDepartment of Human Genetics, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands.
Erasmus MC · NLRadboud University Nijmegen · NLKennedy Krieger Institute · USAmbry Genetics (United States) · USCleveland Clinic · USInserm · FRJohn Radcliffe Hospital · GBSouthern Illinois University School of Medicine · USChildren's National · USCommunity Health Systems - Dupont Hospital · USInstitute of Genetics and Cancer · GBPhoenix Children's Hospital · USUniversity Medical Center Utrecht · NLUniversity of Calgary · CAUniversity of Connecticut · USUniversity of Oxford · GBUniversity of Virginia Medical Center · USVirginia Commonwealth University Medical Center · US

Funding

Department of HealthMedical Research Council MC_UU_00007/3
6 · The paper itself

Abstract

Thousand and one amino-acid kinase 1 (TAOK1) is a MAP3K protein kinase, regulating different mitogen-activated protein kinase pathways, thereby modulating a multitude of processes in the cell. Given the recent finding of TAOK1 involvement in neurodevelopmental disorders (NDDs), we investigated the role of TAOK1 in neuronal function and collected a cohort of 23 individuals with mostly de novo variants in TAOK1 to further define the associated NDD. Here, we provide evidence for an important role for TAOK1 in neuronal function, showing that altered TAOK1 expression levels in the embryonic mouse brain affect neural migration in vivo, as well as neuronal maturation in vitro. The molecular spectrum of the identified TAOK1 variants comprises largely truncating and nonsense variants, but also missense variants, for which we provide evidence that they can have a loss of function or dominant-negative effect on TAOK1, expanding the potential underlying causative mechanisms resulting in NDD. Taken together, our data indicate that TAOK1 activity needs to be properly controlled for normal neuronal function and that TAOK1 dysregulation leads to a neurodevelopmental disorder mainly comprising similar facial features, developmental delay/intellectual disability and/or variable learning or behavioral problems, muscular hypotonia, infant feeding difficulties, and growth problems.

Indexed as

Intellectual DisabilityNeurodevelopmental DisordersAmino AcidsAnimalsHumansMAP Kinase Signaling SystemMiceMuscle HypotoniaAmino Acidscortical developmentfunctional genomicsin utero electroporationneurodevelopmental disordersTAOK1

Identifiers

PMID33565190
PMCPMC8248425
OpenAlexW3129170145

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.